STRATA Skin Sciences Confirms Nasdaq Delisting
Affected assets and topics
Why it matters
STRATA Skin Sciences has filed a Form 25 with the SEC to deregister its common stock, confirming its delisting from the Nasdaq exchange.
Article tone
Expected market reaction
Market impact analysis based on bearish sentiment with 90% confidence.
Evidence trail
Evidence
AI provenance
Technical identifiers
- Provider tag
- groq-llama-3.1-8b-instant
- Analysis version
- groq-llama-3.1-8b-instant
- Article id
- 47846
- Timeframe
- 6h
Prediction lifecycle
-
Llama 3.1 8B Instant (Groq) NASDAQ Bearish 90%Generated 6h Excluded
Expired: not evaluated within 7 days of its 6h timeframe elapsing
Logged at publication, scored automatically once the window closes — never edited.
Original source
HORSHAM, Pa., Feb. 19, 2026 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that a Form 25 has been filed today with the SEC to deregister its common stock under Section 12(b) of the Securities Exchange Act of 1934, as amended (“Exchange Act”), and confirms that trading of the Company’s common s
Read the full article on Yahoo Finance
Original article published by Yahoo Finance on February 20, 2026. Analysis and insights provided by AnalystMarkets AI.